Cardiovascular effects of Danshen
- PMID: 17363091
- DOI: 10.1016/j.ijcard.2007.01.004
Cardiovascular effects of Danshen
Abstract
Danshen is one of the most versatile Chinese herbal drugs that have been used for hundred of years in the treatment of numerous ailments. Because of its properties of improving microcirculation, causing coronary vasodilatation, suppressing the formation of thromboxane, inhibiting platelet adhesion and aggregation, and protecting against myocardial ischemia, it is widely used either alone or in combination with other herbal ingredients for patients with coronary artery disease and other cardiovascular diseases, in both China and other countries including the United States. This article provides an overview of its history, pharmacology, pharmacokinetics, clinical applications, side effects, interactions with Western drugs, and future prospects in the management of cardiovascular diseases.
Similar articles
-
Ameliorating effects of compounds derived from Salvia miltiorrhiza root extract on microcirculatory disturbance and target organ injury by ischemia and reperfusion.Pharmacol Ther. 2008 Feb;117(2):280-95. doi: 10.1016/j.pharmthera.2007.09.008. Epub 2007 Oct 16. Pharmacol Ther. 2008. PMID: 18048101 Review.
-
Danshen (Salvia miltiorrhiza Bunge): A Prospective Healing Sage for Cardiovascular Diseases.Curr Pharm Des. 2017;23(34):5125-5135. doi: 10.2174/1381612823666170822101112. Curr Pharm Des. 2017. PMID: 28828985 Review.
-
Salvia miltiorrhiza and ischemic diseases.Acta Pharmacol Sin. 2000 Dec;21(12):1089-94. Acta Pharmacol Sin. 2000. PMID: 11603281 Review.
-
Herb-drug interactions with Danshen (Salvia miltiorrhiza): a review on the role of cytochrome P450 enzymes.Drug Metabol Drug Interact. 2012 Mar 2;27(1):9-18. doi: 10.1515/dmdi-2011-0038. Drug Metabol Drug Interact. 2012. PMID: 22718621 Review.
-
Salvia miltiorrhiza treatment during early reperfusion reduced postischemic myocardial injury in the rat.Can J Physiol Pharmacol. 2007 Oct;85(10):1012-9. doi: 10.1139/y07-092. Can J Physiol Pharmacol. 2007. PMID: 18066102
Cited by
-
The efficacy of guanxinning injection in treating angina pectoris: systematic review and meta-analysis of randomized controlled trials.Evid Based Complement Alternat Med. 2013;2013:282707. doi: 10.1155/2013/282707. Epub 2013 Mar 24. Evid Based Complement Alternat Med. 2013. PMID: 23634167 Free PMC article.
-
Effect of Dan Hong injection on PON1, SOD activity and MDA levels in elderly patients with coronary heart disease.Int J Clin Exp Med. 2014 Dec 15;7(12):5886-9. eCollection 2014. Int J Clin Exp Med. 2014. PMID: 25664126 Free PMC article.
-
Adjuvant Chinese Herbal Products for Preventing Ischemic Stroke in Patients with Atrial Fibrillation.PLoS One. 2016 Jul 18;11(7):e0159333. doi: 10.1371/journal.pone.0159333. eCollection 2016. PLoS One. 2016. PMID: 27428543 Free PMC article.
-
Isolation and Comprehensive in Silico Characterisation of a New 3-Hydroxy-3-Methylglutaryl-Coenzyme A Reductase 4 (HMGR4) Gene Promoter from Salvia miltiorrhiza: Comparative Analyses of Plant HMGR Promoters.Plants (Basel). 2022 Jul 16;11(14):1861. doi: 10.3390/plants11141861. Plants (Basel). 2022. PMID: 35890495 Free PMC article.
-
Sodium Tanshinone II-A Sulfonate (DS-201) Induces Vasorelaxation of Rat Mesenteric Arteries via Inhibition of L-Type Ca2+ Channel.Front Pharmacol. 2018 Feb 2;9:62. doi: 10.3389/fphar.2018.00062. eCollection 2018. Front Pharmacol. 2018. PMID: 29456510 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical